Europe Drug Delivery Market is expected to reach USD 536.1 billion by 2024 from USD 305.5 billion in 2016, at a CAGR of 7.3% in the forecast period 2017 to 2024.
- Advertising -
The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Europe drug delivery market is the second largest revenue pocket for the global drug delivery devices manufacturers with 29.9% market share in 2016.
Sample Report @ databridgemarketresearch.com/reque…ry-devices-market
This report consists of below pages:
- No of pages: 175
- No of Figures: 30
- No of Tables: 125
Major Market Drivers and Restraints:
- Growing Industry-Academia Collaborations
- Increasing R&D activities and expenditure
- Quality concerns
- Technological developments
- Increasing funding for proteomics research and drug discovery
The Europe drug delivery market is segmented on the basis of product type, technology, components, delivery mode, end-user, and geography.
- Advertising -
Browse Full Report @ databridgemarketresearch.com/repor…y-devices-market/
On the basis of route of administration the Europe drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs.
The liquid drugs are further classified into solutions and syrups. Based on the route of administration, oral drug delivery market dominates the market in 2016 with 44.5% market share.
Injectable drug delivery market is considered to be the fastest growing market with the CAGR of 11.7%.
Request for TOC: databridgemarketresearch.com/toc/?…ry-devices-market
Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices.
The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes. The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable.
The Europe pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
The Europe ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays.
Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
The Europe Nasal drug delivery devices are segmented on the basis of product type into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented on the basis of product form into liquid, semi-solid, solid and transdermal.
The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices.
The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of end users the Europe drug delivery market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. In 2016, the hospitals segment dominates the Europe drug delivery market with more than 60.6% market share.
Based on geography the market is segmented into 11 countries, Germany, France, U.K., Spain, Italy, Russia, Netherlands, Switzerland, Turkey, Belgium, and Rest of Europe. Germany is expected to dominate the market with largest share of 23.6% in 2016.
However the drug delivery market in France is expected to be the fastest growing among the other countries in Europe.
The Europe Drug Delivery Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major players operating in this market are
- Bayer AG
- Johnson & Johnson
- Novartis AG
- Pfizer, Inc.
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc.
- Merck & Co.
- Antares Pharma
- Becton Dickinson and Company
- Biolase, Inc.
- Cima Labs, Inc.
- West Pharmaceuticals
- Antares Pharma
- Skyepharma AG
- Valeant Pharmaceuticals
- DSM Biomedical
- Catalent, Inc.
Enquire about report @ databridgemarketresearch.com/inqui…ry-devices-market
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: